5.5 minute read
Meeting the creditable coverage standard could be tougher in 2025 due to a richer Part D standard benefit. Plan sponsors with rich prescription drug coverage may remain unaffected, while those barely meeting the 2024 standard might not pass in 2025. Some may enhance benefits to maintain status, others might let plans go non-creditable after a cost-benefit analysis. Plan sponsors should confirm creditable status early to evaluate options and make final decisions.
Note: NIS is sharing this blog from our parent company, AssuredPartners, Inc.
